Jiahao Qiu

机构：Princeton University, Shanghai University of Traditional Chinese Medicine, Shuguang Hospital · ORCID：0009-0001-2770-349X

发表论文 11 篇 · 总被引 909 次 · h-index 7

代表论文

• Tumor biomarkers for diagnosis, prognosis and targeted therapy (2024 · Signal Transduction and Targeted Therapy · 被引 674)
• Epigenetic regulation in cancer therapy: From mechanisms to clinical advances (2024 · MedComm – Oncology · 被引 81)
• Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51 (2023 · Nature Communications · 被引 35)
• Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1 (2023 · Phytomedicine · 被引 31)
• Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B (2023 · MedComm · 被引 17)
• LPM3770277, a Potent Novel CDK4/6 Degrader, Exerts Antitumor Effect Against Triple-Negative Breast Cancer (2022 · Frontiers in Pharmacology · 被引 15)